GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Withdrawal of Possible Offer for TP Group plc

3 Sep 2021 12:00

RNS Number : 7101K
Science Group PLC
03 September 2021
 

 

 

 

 

3 September 2021

 

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

FOR IMMEDIATE RELEASE

 

 

Withdrawal of Possible Offer for TP Group plc ("TP Group" or the "Company")

 

At 7am on 3 September 2021, Science Group holds 188,049,663 shares in TP Group, equivalent to approx. 24.1% of the Company's issued voting share capital. The highest price paid by Science Group has been 6.5 pence per TP Group share. According to disclosures, Science Group is the largest shareholder in TP Group.

 

As set out in prior announcements, the indicative offer by Science Group was subject to certain pre-conditions, including the completion of satisfactory due diligence. This condition to Science Group's indicative offer was not capable of being waived. The Board of TP Group have been unwilling to provide access to due diligence information unless certain conditions were agreed which are unacceptable to Science Group. Notwithstanding such conditions, TP Group have declined to even define the content and extent of such due diligence information if it were to be provided, nor have they responded to other pre-conditions within the Science Group indicative offer.

 

Science Group therefore announces the withdrawal, under Rule 2.8 of the Code, of its indicative offer of 6.5 pence per share and confirms that Science Group no longer intends to make an offer for TP Group. The Science Group indicative offer represented an approx. 67% premium to the TP Group closing share price on the last trading day prior to Science Group's investment. The lack of cooperation from the TP Group Board means that TP Group shareholders will be denied this attractive liquidity opportunity.

 

For the purposes of Rule 2.8 of the Code, Science Group, and any person(s) acting in concert with it, reserve the right to make or participate in an offer or possible offer for TP Group (and to take any other action which would otherwise be restricted under Rule 2.8 of the Code) within 6 months after the date of this announcement:

· with the agreement of the TP Group Board;

· following the announcement of a firm intention to make an offer for TP Group by or on behalf of a third party;

· following the announcement by TP Group of a proposal for a "whitewash" (as referred to in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or for a reverse takeover (as defined in the Code); or

· where the Panel on Takeovers and Mergers has determined that there has been a material change of circumstances.

Strategic Investment and General Meeting Requisition

 

As stated previously, Science Group will retain its shareholding in TP Group as a strategic investment. This strategy is in line with the statement made by Science Group on 24 January 2019, concluding the Corporate Strategic Review that "the Board will consider opportunities to acquire a major shareholding rather than make a full acquisition, if appropriate."

Science Group will adopt an active engagement strategy and is not interested in considering any offers for its stake in TP Group from third parties. Science Group reserves the right to make further purchases of TP Group shares in the market, up to a maximum of 29.9% of the issued voting share capital, and is not restricted on the price it pays for any such purchases.

On 17 August 2021, TP Group acknowledged that it is "required to convene a general meeting" to enable TP Group shareholders to consider the constitution of the TP Group plc Board. In the opinion of Science Group, the notice of general meeting should be despatched to TP Group shareholders by no later than Monday 6 September 2021 and convened on or before 4 October 2021. Science Group anticipates making further statements in relation to the TP Group general meeting in due course.

 

 

 

End

 

Science Group plc Tel: +44 (0) 1223 875 200

Martyn Ratcliffe, Chairman www.sciencegroup.com

Stifel Nicolaus Europe Limited (Financial Adviser, Tel: +44 (0) 20 7710 7600

Nominated Adviser and Joint Broker)

Nick Adams, Alex Price, Richard Short

Liberum Capital Limited (Joint Broker) Tel: +44 (0) 20 3100 2000

Neil Patel, Cameron Duncan

 

MHP Communications (PR Adviser to Science Group) Tel: +44 ( 0)20 3128 8793

Reg Hoare

 

Further information

The person responsible for the release of this announcement on behalf of Science Group is Martyn Ratcliffe, Chairman of Science Group.

This announcement is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction.

The release, publication or distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe such restrictions. Any failure to comply with such restrictions may constitute a violation of the securities law of any such jurisdiction.

Stifel Nicolaus Europe Limited ("Stifel"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as Financial Adviser exclusively for Science Group and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Science Group for providing the protections afforded to clients of Stifel, nor for providing advice in relation to any matter referred to herein.

Sources of financial information and bases of calculation

The closing mid-market share prices for TP Group shares have been derived from the Daily Official List.

The premium calculation per TP Group share is by reference to 3.9 pence, being the closing mid-market share price on 6 August 2021, the last trading day prior to Science Group's share purchase.

Publication on Website

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at https://www.sciencegroup.com/investor-information/ promptly and in any event by no later than 12 noon on the business day following this announcement. The content of this website is not incorporated into and does not form part of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKNBPKBKDACK
Date   Source Headline
31st Jul 20174:50 pmRNSHolding(s) in Company
31st Jul 201711:25 amRNSHolding(s) in Company
31st Jul 20178:10 amRNSHoldings in Company
28th Jul 201711:07 amRNSDirectors' Dealings
28th Jul 20178:07 amRNSTrading Update and Completion of Fundraising
27th Jul 201711:46 amRNSResult of General Meeting and Issue of Equity
27th Jul 20177:00 amRNSResult of Open Offer
25th Jul 20177:00 amRNSNotice of Half-Year Results
24th Jul 20177:00 amRNS£1.9m Export Defence Contract Award
10th Jul 201712:45 pmRNSPublication of Circular
10th Jul 20177:00 amRNSConditional Fundraising
22nd Jun 20177:00 amRNSTP Group admitted to Defence Services Framework
25th May 20172:00 pmRNSResult of AGM
25th May 20177:00 amRNSAGM Statement
9th May 201711:45 amRNSReplacement and grant of share options
4th May 20177:00 amRNSContract Update
11th Apr 201712:00 pmRNSConfirmation of contract award
11th Apr 20177:00 amRNSPublication of Annual Report and Notice of AGM
6th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSFinal Results
3rd Apr 20177:00 amRNSConfirmation of contract award
2nd Mar 20175:45 pmRNSAppointment of Non-Executive Director -Replacement
27th Feb 20177:00 amRNSAppointment of Non-Executive Director
21st Feb 20177:00 amRNSBoard Appointment
16th Feb 20174:40 pmRNSHoldings in Company
7th Feb 20177:00 amRNSAcquisition
25th Jan 20177:00 amRNSTrading Update and Notice of Results
16th Dec 201610:00 amRNSHolding(s) in Company
15th Dec 20167:00 amRNSBoard Change
14th Dec 20167:00 amRNSTrading Update
6th Dec 201611:23 amRNSContract Win
29th Nov 201610:30 amRNSTPG secures BAE Systems contract
24th Nov 20161:00 pmRNSHolding(s) in Company
12th Oct 20167:00 amRNSContract win
28th Sep 20163:00 pmRNSCapital Reduction Effective
13th Sep 20167:00 amRNSContract win
13th Sep 20167:00 amRNSInterim Report for six months ended 30 June 2016
8th Sep 201610:49 amRNSResult of General Meeting
31st Aug 20167:00 amRNSContract Win
19th Aug 20167:00 amRNSProposed Reduction of Capital and Notice of GM
5th Aug 201611:45 amRNSContract update
20th Jul 20167:00 amRNSContract Award
13th Jul 20167:00 amRNSTrading Update and Notice of Half-Year Results
4th Jul 20163:00 pmRNSContract update
30th Jun 20162:45 pmRNSDirector/PDMR Shareholding
21st Jun 201611:00 amRNSDirector/PDMR Shareholding
21st Jun 20167:00 amRNSDirector/PDMR Shareholding
17th Jun 20167:00 amRNSBoard Change
14th Jun 201611:45 amRNSResult of AGM
18th May 20164:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.